Across TCGA pan-cancer cohorts, UGT2B25P RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of UGT2B25P’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where UGT2B25P RNA is repressed in tumor relative to normal tissue. In most cancer types UGT2B25P is over-expressed in tumor, although a few such as COAD show the opposite, repressed pattern.

COAD are the cancer types where UGT2B25P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in UGT2B25P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Female	All	−0.016	.001	5	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: UGT2B25P RNA expression & survival · all UGT2B25P data types